Metronidazol Ziaja

Metronidazole, the active ingredient in Metronidazol Ziaja, is a nitroimidazole presented as a topical formulation for skin use. It is employed to manage rosacea, acne vulgaris, and other bacterial skin infections in appropriate patients. GNH USA supplies Metronidazol Ziaja as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is used in dermatology to target anaerobic bacteria and inflammatory lesions. - Rosacea: reduces papules, pustules and erythema associated with the condition. - Acne vulgaris: decreases inflammatory lesions and bacterial colonisation of the skin. - Bacterial skin infections: treats localized infections caused by susceptible anaerobic organisms.

Metronidazole topical therapy may cause local and systemic reactions.

Common Side Effects: - Skin irritation: mild redness or itching at the application site. - Dryness: transient scaling or flaking of the treated area. - Burning sensation: brief warmth or tingling after application. - Pruritus: occasional itching unrelated to infection. - Contact dermatitis: mild allergic response in sensitive individuals.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Stevens‑Johnson syndrome: rare severe skin blistering. - Methemoglobinemia: bluish discoloration of skin or lips. - Systemic toxicity: nausea, headache, or dizziness if absorbed in large amounts. - Persistent ulceration: non‑healing skin breakdown at the site.

When using Metronidazol Ziaja, follow these safety measures. - Avoid application on broken or severely inflamed skin: may increase systemic absorption. - Do not use with other topical antibiotics unless directed: risk of irritation. - Limit exposure to eyes and mucous membranes: can cause irritation. - Monitor for signs of allergic reaction: discontinue if severe symptoms develop. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Metronidazol Ziaja may interact with certain systemic agents and topical products.

Major Interactions (Avoid): - Alcohol consumption: risk of disulfiram‑like reaction with systemic absorption. - Concurrent systemic metronidazole: may increase systemic exposure and toxicity.

Moderate Interactions (Monitor Closely): - Other topical antiseptics (e.g., chlorhexidine): potential for increased skin irritation. - Warfarin: systemic absorption could potentiate anticoagulant effect; monitor INR if used long‑term. - Lithium: possible increase in lithium levels with extensive absorption; monitor serum lithium.